Novartis Highlights Patient Engagement-Driven Respiratory Therapeutic Program

May 26, 2019 | Clinical Trials, Novartis, Patient Engagement, Respiratory

Science Business reports on Swiss-based global biopharmaceutical company Novartis and its commitment to patient engagement, whether it be via the patient community, healthcare professionals and research scientists from the pharmaceutical industry.  Novartis understands that committed participation from each groups forms an essential link in the clinical trials value chain.

Novartis is an active participant in respiratory focused clinical trials.  Follow the link to learn more through a series of brief interviews with Novartis clinical trials professionals as well as actual participants in clinical trials.

0 Comments

Pin It on Pinterest